1. Home
  2. VERU vs UFI Comparison

VERU vs UFI Comparison

Compare VERU & UFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • UFI
  • Stock Information
  • Founded
  • VERU 1971
  • UFI 1969
  • Country
  • VERU United States
  • UFI United States
  • Employees
  • VERU N/A
  • UFI N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • UFI Textiles
  • Sector
  • VERU Health Care
  • UFI Consumer Discretionary
  • Exchange
  • VERU Nasdaq
  • UFI Nasdaq
  • Market Cap
  • VERU 85.5M
  • UFI 86.8M
  • IPO Year
  • VERU 1990
  • UFI N/A
  • Fundamental
  • Price
  • VERU $3.60
  • UFI $4.52
  • Analyst Decision
  • VERU Strong Buy
  • UFI
  • Analyst Count
  • VERU 3
  • UFI 0
  • Target Price
  • VERU $33.33
  • UFI N/A
  • AVG Volume (30 Days)
  • VERU 227.6K
  • UFI 44.1K
  • Earning Date
  • VERU 08-12-2025
  • UFI 08-20-2025
  • Dividend Yield
  • VERU N/A
  • UFI N/A
  • EPS Growth
  • VERU N/A
  • UFI N/A
  • EPS
  • VERU N/A
  • UFI N/A
  • Revenue
  • VERU $16,886,419.00
  • UFI $571,344,000.00
  • Revenue This Year
  • VERU N/A
  • UFI $1.08
  • Revenue Next Year
  • VERU N/A
  • UFI $9.96
  • P/E Ratio
  • VERU N/A
  • UFI N/A
  • Revenue Growth
  • VERU 337.24
  • UFI N/A
  • 52 Week Low
  • VERU $2.64
  • UFI $4.25
  • 52 Week High
  • VERU $14.20
  • UFI $7.91
  • Technical
  • Relative Strength Index (RSI)
  • VERU 35.24
  • UFI 40.00
  • Support Level
  • VERU $2.64
  • UFI $4.35
  • Resistance Level
  • VERU $3.69
  • UFI $4.60
  • Average True Range (ATR)
  • VERU 0.39
  • UFI 0.22
  • MACD
  • VERU 0.02
  • UFI 0.00
  • Stochastic Oscillator
  • VERU 40.27
  • UFI 16.07

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

Share on Social Networks: